BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14994141)

  • 1. Gastrointestinal carcinoid tumors: factors that predict outcome.
    Van Gompel JJ; Sippel RS; Warner TF; Chen H
    World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.
    Shebani KO; Souba WW; Finkelstein DM; Stark PC; Elgadi KM; Tanabe KK; Ott MJ
    Ann Surg; 1999 Jun; 229(6):815-21; discussion 822-3. PubMed ID: 10363895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients.
    Söreide JA; van Heerden JA; Thompson GB; Schleck C; Ilstrup DM; Churchward M
    World J Surg; 2000 Nov; 24(11):1431-6. PubMed ID: 11038218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases.
    Mårtensson H; Nobin A; Sundler F
    Acta Chir Scand; 1983; 149(6):607-16. PubMed ID: 6650073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.
    Perez EA; Koniaris LG; Snell SE; Gutierrez JC; Sumner WE; Lee DJ; Hodgson NC; Livingstone AS; Franceschi D
    World J Surg; 2007 May; 31(5):1022-30. PubMed ID: 17429568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical therapy of carcinoid tumors of the gastrointestinal tract].
    Böttger T
    Zentralbl Chir; 2001 Sep; 126(9):676-81. PubMed ID: 11699282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.
    Eriksson J; Stålberg P; Nilsson A; Krause J; Lundberg C; Skogseid B; Granberg D; Eriksson B; Akerström G; Hellman P
    World J Surg; 2008 May; 32(5):930-8. PubMed ID: 18324347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.
    Thompson GB; van Heerden JA; Martin JK; Schutt AJ; Ilstrup DM; Carney JA
    Surgery; 1985 Dec; 98(6):1054-63. PubMed ID: 4071383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
    Kirshbom PM; Kherani AR; Onaitis MW; Feldman JM; Tyler DS
    Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal carcinoids: the most frequent carcinoid tumor.
    Jetmore AB; Ray JE; Gathright JB; McMullen KM; Hicks TC; Timmcke AE
    Dis Colon Rectum; 1992 Aug; 35(8):717-25. PubMed ID: 1643994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foregut carcinoids: a clinical and biochemical analysis.
    Kirshbom PM; Kherani AR; Onaitis MW; Hata A; Kehoe TE; Feldman C; Feldman JM; Tyler DS
    Surgery; 1999 Dec; 126(6):1105-10. PubMed ID: 10598194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal carcinoids: an increasing incidence of rectal distribution.
    Avenel P; McKendrick A; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Goriel Y; Mittal V
    Am Surg; 2010 Jul; 76(7):759-63. PubMed ID: 20698387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin.
    Jaffee IM; Rahmani M; Singhal MG; Younes M
    Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal carcinoid tumors.
    Eller R; Frazee R; Roberts J
    Am Surg; 1991 Jul; 57(7):434-7. PubMed ID: 2058850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and prognosis of gastrointestinal carcinoid tumours.
    Sjöblom SM
    Scand J Gastroenterol; 1988 Sep; 23(7):779-87. PubMed ID: 3227292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies.
    Gerstle JT; Kauffman GL; Koltun WA
    J Am Coll Surg; 1995 Apr; 180(4):427-32. PubMed ID: 7719546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.